In a landmark achievement for genetic research in India, scientists at the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad have successfully used CRISPR-Cas9 gene editing technology to correct a disease-causing mutation in human cells derived from a patient suffering from a rare inherited disorder. This breakthrough, announced earlier today, offers renewed hope for treating genetic diseases that were previously considered incurable.

The research, led by Dr. Arundhati Sharma, focused on a specific mutation responsible for early-onset macular degeneration, a condition causing progressive vision loss. Using CRISPR-Cas9, the research team precisely targeted and corrected the faulty gene in cells cultured in the lab. This is the first time such precise gene editing has been achieved on human cells for this specific genetic condition by an Indian research team. As of March 2026, this puts India at the forefront of gene editing research globally.

CRISPR-Cas9: A Molecular Scalpel for Gene Editing

CRISPR-Cas9 is a revolutionary gene editing tool that acts like a molecular scalpel, allowing scientists to precisely cut and modify DNA sequences. Imagine our DNA as a long book containing instructions for building and maintaining our bodies. Sometimes, there are typos in this book – these are the genetic mutations that can cause diseases. CRISPR-Cas9 allows us to precisely find and correct these typos, effectively rewriting the genetic code. Dr. Sharma explained the process, saying, "We designed a guide RNA molecule that specifically targets the mutated gene. The Cas9 enzyme then acts like scissors, cutting the DNA at that precise location, allowing the cell's natural repair mechanisms to correct the mutation."

The technique has been adapted from a naturally occurring genome editing system that bacteria use as an immune defense. The applications of CRISPR technology are vast, ranging from correcting genetic defects to developing new diagnostic tools and therapies for various diseases. This work builds upon previous successes of other Indian scientific institutions. Science News has been closely following the development of gene editing technologies over the past few years.

Implications for Treating Genetic Diseases

This successful gene editing experiment opens the door to potential treatments for various inherited diseases prevalent in the Indian population. While the current research is limited to cell cultures in the lab, the next step involves pre-clinical studies using animal models, followed by human clinical trials. "This is just the beginning. We are hopeful that this technology can be translated into effective therapies for patients suffering from genetic disorders," reportersays Dr. Sharma, speaking to News Reporter Live. "Our work provides a strong foundation for developing gene-based therapies tailored to the specific genetic makeup of Indian patients."

Future Research Directions and Challenges

The researchers acknowledge that significant challenges remain before CRISPR-based therapies can become a reality. Ensuring the safety and efficacy of the gene editing process is paramount. One of the key challenges is to minimize off-target effects, where the CRISPR-Cas9 system accidentally edits genes at unintended locations. Delivering the gene editing machinery specifically to the affected cells in the body is another hurdle that needs to be overcome. Meanwhile, research is ongoing at IIT Madras to develop more efficient delivery methods. The team is also working on expanding the application of CRISPR-Cas9 to other genetic diseases, including thalassemia and sickle cell anemia, which are common in India. CBSE Study Materials cover the basics of genetics.

The Department of Biotechnology, Government of India, has been instrumental in funding and supporting this groundbreaking research. The success of this project highlights the growing capabilities of Indian scientists in the field of genetic engineering and their commitment to developing innovative solutions for healthcare challenges.